Tag Archives: Patent Law

Court Decision in China Recognizes Novelty in Dosage Limitations in Swiss-Form Claims

Posted on February 3, 2010 by Warren Woessner

Peksung Intellectual Property Ltd sent an interesting article (link below) reporting that the Higher People’s Court of Beijing held that both dosage form and dosage amount should be treated as limitations in Swiss-form claims. These “administration-related features” are often ignored … Continue reading →

Posted in Non-U.S. Practice | Tagged , , , | Leave a comment

ALCHEMISTS’ LINK TO CHEM/PHARMA GOLD

Posted on January 15, 2010 by Warren Woessner

This link below will lead you to a wealth of recent chem/pharma caselaw and policy materials organized by Kevin Buckley for his lectures on Biotechnology Law at Washington University in St. Louis School of Law. Like the fabled Alchemists’ Stone, … Continue reading →

Posted in 2010 Patent News | Tagged , , | Leave a comment

BACK TO THE O.K. CORRAL – SHOULD PROFESSORS MANAGE IP LICENSING?

Posted on January 13, 2010 by Warren Woessner

Last summer, Bob Litan and Lesa Mitchell of the Kauffman Foundation sent a short memo to Esther Lee at the Dept. of Commerce entitled “Accelerating the Commercialization of Government-Funded University-Based Research.” Although the Foundation, based in Kansas City MO, has … Continue reading →

Posted in Tech Transfer | Tagged , , , , , , , , | 1 Comment

You Say Tomato . . . I Say Tah-mah-to . . . Hewlett-Packard Company v. Acceleron LLC

Posted on December 28, 2009 by Warren Woessner

Authored by Ronald J Schutz of Robins Kaplan Miller & Ciresi LLP The Federal Circuit says: “declaratory judgment jurisdiction,” even if the patent holder’s notice letter waltzes around buy cialis online uk phrases like “infringement” or “assertion.” In Hewlett-Packard Company … Continue reading →

Posted in Litigation Issues | Tagged , , , , | Leave a comment